United States Apremilast Market Report 2016

November 2016 | 103 pages | ID: U5A0F76562CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Apremilast

Revenue, means the sales value of Apremilast

This report studies sales (consumption) of Apremilast in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• AryoGen Biopharma
• Sanofi
• Celltrion
• Delenex Therapeutics
• LEO Pharma
• Delenex Therapeutics
• Ablynx
• Shanghai CP Guojian Pharmaceutical
• Tsumura

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Apremilast in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Apremilast Market Report 2016

1 APREMILAST OVERVIEW

1.1 Product Overview and Scope of Apremilast
1.2 Classification of Apremilast
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Apremilast
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Apremilast (2011-2021)
  1.4.1 United States Apremilast Sales and Growth Rate (2011-2021)
  1.4.2 United States Apremilast Revenue and Growth Rate (2011-2021)

2 UNITED STATES APREMILAST COMPETITION BY MANUFACTURERS

2.1 United States Apremilast Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Apremilast Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Apremilast Average Price by Manufactures (2015 and 2016)
2.4 Apremilast Market Competitive Situation and Trends
  2.4.1 Apremilast Market Concentration Rate
  2.4.2 Apremilast Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES APREMILAST SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Apremilast Sales and Market Share by Type (2011-2016)
3.2 United States Apremilast Revenue and Market Share by Type (2011-2016)
3.3 United States Apremilast Price by Type (2011-2016)
3.4 United States Apremilast Sales Growth Rate by Type (2011-2016)

4 UNITED STATES APREMILAST SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Apremilast Sales and Market Share by Application (2011-2016)
4.2 United States Apremilast Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES APREMILAST MANUFACTURERS PROFILES/ANALYSIS

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Apremilast Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlaxoSmithKline Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AryoGen Biopharma
  5.2.2 Apremilast Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AryoGen Biopharma Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Apremilast Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Celltrion
  5.4.2 Apremilast Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Celltrion Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Delenex Therapeutics
  5.5.2 Apremilast Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Delenex Therapeutics Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 LEO Pharma
  5.6.2 Apremilast Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 LEO Pharma Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Delenex Therapeutics
  5.7.2 Apremilast Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Delenex Therapeutics Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Ablynx
  5.8.2 Apremilast Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Ablynx Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Shanghai CP Guojian Pharmaceutical
  5.9.2 Apremilast Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Shanghai CP Guojian Pharmaceutical Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Tsumura
  5.10.2 Apremilast Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Tsumura Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 APREMILAST MANUFACTURING COST ANALYSIS

6.1 Apremilast Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Apremilast

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Apremilast Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Apremilast Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES APREMILAST MARKET FORECAST (2016-2021)

10.1 United States Apremilast Sales, Revenue Forecast (2016-2021)
10.2 United States Apremilast Sales Forecast by Type (2016-2021)
10.3 United States Apremilast Sales Forecast by Application (2016-2021)
10.4 Apremilast Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Apremilast
Table Classification of Apremilast
Figure United States Sales Market Share of Apremilast by Type in 2015
Table Application of Apremilast
Figure United States Sales Market Share of Apremilast by Application in 2015
Figure United States Apremilast Sales and Growth Rate (2011-2021)
Figure United States Apremilast Revenue and Growth Rate (2011-2021)
Table United States Apremilast Sales of Key Manufacturers (2015 and 2016)
Table United States Apremilast Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Apremilast Sales Share by Manufacturers
Figure 2016 Apremilast Sales Share by Manufacturers
Table United States Apremilast Revenue by Manufacturers (2015 and 2016)
Table United States Apremilast Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Apremilast Revenue Share by Manufacturers
Table 2016 United States Apremilast Revenue Share by Manufacturers
Table United States Market Apremilast Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Apremilast Average Price of Key Manufacturers in 2015
Figure Apremilast Market Share of Top 3 Manufacturers
Figure Apremilast Market Share of Top 5 Manufacturers
Table United States Apremilast Sales by Type (2011-2016)
Table United States Apremilast Sales Share by Type (2011-2016)
Figure United States Apremilast Sales Market Share by Type in 2015
Table United States Apremilast Revenue and Market Share by Type (2011-2016)
Table United States Apremilast Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Apremilast by Type (2011-2016)
Table United States Apremilast Price by Type (2011-2016)
Figure United States Apremilast Sales Growth Rate by Type (2011-2016)
Table United States Apremilast Sales by Application (2011-2016)
Table United States Apremilast Sales Market Share by Application (2011-2016)
Figure United States Apremilast Sales Market Share by Application in 2015
Table United States Apremilast Sales Growth Rate by Application (2011-2016)
Figure United States Apremilast Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Apremilast Sales Market Share (2011-2016)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table AryoGen Biopharma Apremilast Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Apremilast Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Apremilast Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Apremilast Sales Market Share (2011-2016)
Table LEO Pharma Basic Information List
Table LEO Pharma Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table LEO Pharma Apremilast Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Apremilast Sales Market Share (2011-2016)
Table Ablynx Basic Information List
Table Ablynx Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ablynx Apremilast Sales Market Share (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Basic Information List
Table Shanghai CP Guojian Pharmaceutical Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Apremilast Sales Market Share (2011-2016)
Table Tsumura Basic Information List
Table Tsumura Apremilast Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tsumura Apremilast Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Apremilast
Figure Manufacturing Process Analysis of Apremilast
Figure Apremilast Industrial Chain Analysis
Table Raw Materials Sources of Apremilast Major Manufacturers in 2015
Table Major Buyers of Apremilast
Table Distributors/Traders List
Figure United States Apremilast Production and Growth Rate Forecast (2016-2021)
Figure United States Apremilast Revenue and Growth Rate Forecast (2016-2021)
Table United States Apremilast Production Forecast by Type (2016-2021)
Table United States Apremilast Consumption Forecast by Application (2016-2021)